The Cigna Group
CI
Positions held
Your positionsCI isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-07.
- Cigna Group is well-positioned in the healthcare plans industry, benefiting from a growing demand for health insurance and services as the population ages.
- Revenue increased by 5% compared to the prior quarter, reaching $71.4 billion.
- The company has a strong earnings growth rate of 10.2%, indicating robust profitability potential.
- Cigna faces significant competition in the healthcare sector, which may pressure margins and market share.
- Gross margin decreased to 8.8%, down from 9.2% in the previous quarter.
- The current ratio is 0.846, suggesting potential liquidity concerns.
Fundamentals
| Market cap | $74.26B | Enterprise value | $99.17B | Trailing P/E | 11.62 | Forward P/E | 8.39 |
| PEG | 0.76 | Price / book | 1.74 | Beta | 0.30 | Dividend yield | 2.22% |
| Revenue growth | 6.7% | Earnings growth | 10.2% | Gross margin | 9.1% | Operating margin | 4.0% |
| Profit margin | 2.3% | ROE | 16.8% | ROA | 4.5% | Debt / equity | 0.74 |
| Current ratio | 0.85 | Free cash flow | $7.98B | Analyst recommendation | buy | Mean target | $342.29 |
| 52w high | $312.18 | 52w low | $239.51 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $71.4B | $68.3B | $72.1B | $69.5B | $66.9B | — |
| Op margin | 3.4% | 3.2% | 2.8% | 3.4% | 3.1% | — |
| Net income | $1.7B | $1.7B | $1.2B | $1.9B | $1.5B | — |
| Gross margin | 8.8% | 9.2% | 8.4% | 8.8% | 8.9% | — |
| Gross profit | $6.3B | $6.3B | $6.1B | $6.1B | $5.9B | — |
| Operating income | $2.4B | $2.2B | $2.0B | $2.3B | $2.1B | — |
- Revenue +5% vs prior quarter ($71.4B vs $68.3B).
- Gross margin 8.8% (was 9.2% prior quarter).
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $273.9B | $246.1B | $194.1B | $179.4B | — |
| Op margin | 3.0% | 3.4% | 3.8% | 4.1% | — |
| Net income | $6.0B | $3.4B | $5.2B | $6.7B | — |
| Gross margin | 9.0% | 10.2% | 12.4% | 12.5% | — |
| Gross profit | $24.5B | $25.0B | $24.0B | $22.3B | — |
| Operating income | $8.2B | $8.4B | $7.4B | $7.3B | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-09 · CVS Health (CVS) vs Cigna (CI): Which is a Better Stock to Buy?
2026-10-09 · The Cigna Group's Third Quarter 2026 Earnings Release Details
2026-10-08 · Is Hims & Hers Stock Ready For A Longer Cash Burn?
2026-10-05 · 2 Safe-and-Steady Stocks with Promising Prospects and 1 We Turn Down
2026-10-03 · The Insurance Industry Is Shedding Jobs. It’s Not All About AI.
2026-10-03 · 3 Cash Rich US Stocks Investors Are Watching As Bond Yields Stay High
2026-10-02 · Piper Sandler Adjusts Cigna Price Target to $370 From $346, Maintains Overweight Rating
2026-10-02 · Bernstein Adjusts Cigna Price Target to $387 From $381, Maintains Outperform Rating
2026-10-02 · How Much Downside Is Left In CVS Health Stock?
2026-10-01 · Cigna Better Positioned to Meet Long-Term EPS Growth Targets, RBC Says
2026-10-01 · Jefferies Adjusts Price Target on Cigna Group to $288 From $307, Keeps Hold Rating
Price (daily)
Full chart · RSI · MACD · patterns